BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 12222136)

  • 1. [New trends in the diagnosis and treatment of renal cell carcinoma].
    Zisman A
    Harefuah; 2002 Aug; 141(8):713-7, 761. PubMed ID: 12222136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic and partial nephrectomy.
    Novick AC
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6322S-7S. PubMed ID: 15448025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of large renal tumors.
    Wszolek MF; Wotkowicz C; Libertino JA
    Nat Clin Pract Urol; 2008 Jan; 5(1):35-46. PubMed ID: 18185512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing concepts in the surgical management of renal cell carcinoma.
    Lam JS; Shvarts O; Pantuck AJ
    Eur Urol; 2004 Jun; 45(6):692-705. PubMed ID: 15149740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma: current status and future prospects.
    Drucker BJ
    Cancer Treat Rev; 2005 Nov; 31(7):536-45. PubMed ID: 16236454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors and molecular markers for renal cell carcinoma.
    Bui MH; Zisman A; Pantuck AJ; Han KR; Wieder J; Belldegrun AS
    Expert Rev Anticancer Ther; 2001 Dec; 1(4):565-75. PubMed ID: 12113089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
    Pantuck AJ; Belldegrun AS; Figlin RA
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):693s-696s. PubMed ID: 17255295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant autologous tumour cell-lysate vaccine versus no adjuvant treatment in patients with M0 renal cell carcinoma after radical nephrectomy: 3-year interim analysis of a German multicentre phase-III trial.
    Doehn Ch; Richter A; Lehmacher W; Jocham D
    Folia Biol (Praha); 2003; 49(2):69-73. PubMed ID: 12779015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the incidentally detected solid renal mass.
    Novick AC
    Semin Nephrol; 1994 Nov; 14(6):519-22. PubMed ID: 7855459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Finelli A; Kaouk JH; Fergany AF; Abreu SC; Novick AC; Gill IS
    BJU Int; 2004 Aug; 94(3):291-4. PubMed ID: 15291853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma in children and adolescents.
    Spreafico F; Collini P; Terenziani M; Marchianò A; Piva L
    Expert Rev Anticancer Ther; 2010 Dec; 10(12):1967-78. PubMed ID: 21110762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
    Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
    Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma: current status and emerging therapies.
    Nelson EC; Evans CP; Lara PN
    Cancer Treat Rev; 2007 May; 33(3):299-313. PubMed ID: 17329029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD70: a new tumor specific biomarker for renal cell carcinoma.
    Junker K; Hindermann W; von Eggeling F; Diegmann J; Haessler K; Schubert J
    J Urol; 2005 Jun; 173(6):2150-3. PubMed ID: 15879877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cell carcinoma in children: single-center experience.
    Helmy T; Sarhan O; Sarhan M; El-Baz M; Dawaba M; Ghali A
    J Pediatr Surg; 2009 Sep; 44(9):1750-3. PubMed ID: 19735820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Margulis V; Matin SF; Wood CG
    Curr Opin Urol; 2008 Sep; 18(5):474-80. PubMed ID: 18670270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of renal cell carcinoma with vena cava tumor thrombi].
    Li XF; Zhou FJ; Qiu SP; Liu ZW; Wu RP; Huang K; Mei H
    Ai Zheng; 2004 Sep; 23(9):1074-6. PubMed ID: 15363205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in renal cell carcinoma.
    Shuch BM; Lam JS; Belldegrun AS; Figlin RA
    Semin Oncol; 2006 Oct; 33(5):563-75. PubMed ID: 17045085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.